azasteroids - CISMeF

Preferred Label : azasteroids;

MeSH definition : Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with nitrogen atoms.;

MeSH synonym : Azasteroid;

MeSH hyponym : 4 Azasteroids; Azasteroids, 4-; 17 Azasteroids; Azasteroids, 17-;

Is substance : O;

Details

Origin ID

D001378;

UMLS CUI

C0004481;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Azasteroid (substance) [SNOMED CT concept]
Pharmacological action(s)
- 5-alpha reductase inhibitors [MeSH Descriptor]
Record concept(s)
- 17- Azasteroids [MeSH concept]
- 4- Azasteroids [MeSH concept]
- azasteroids [MeSH concept]
Related MeSH Supplementary Concept(s)
- (22RS-N-1,1,1-trifluoro-2-phenylprop-2-yl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide [MeSH Supplementary Concept]
- (3-oxo-4-methylazaandrost-1-ene-17-yl)-2,2,2-trifluoroethyl ester carbamic acid [MeSH Supplementary Concept]
- (5alpha)-23-methyl-4-aza-21-norchol-1-ene-3,20-dione [MeSH Supplementary Concept]
- 16-oxo-17-azaandrost-5-en-3-ol acetate [MeSH Supplementary Concept]
- 17-N,N-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one [MeSH Supplementary Concept]
- 17-N,N-diisopropylcarbamoyl-4-azaandrostan-3-one [MeSH Supplementary Concept]
- 17-acetamido-3-aza-A-homo-4-androsten-4-one [MeSH Supplementary Concept]
- 17-aza-homo-delta (1,3,5(10)) estratrien-3-ol-17-one-4-N,N-bis(2-chloroethyl)aminophenylacetate [MeSH Supplementary Concept]
- 17-hydroxy-3-aza-A-homo-4-androsten-4-one (4-(bis(2-chloroethyl)amino)phenyl)butyrate [MeSH Supplementary Concept]
- 17-hydroxy-4-aza-A-nor-5-androsten-3-one (4-N,N-bis(2-chloroethylamino)phenyl)butyrate [MeSH Supplementary Concept]
- 17-isopentyloxy-4-azaandrostane [MeSH Supplementary Concept]
- 2'-(4-fluorophenyl)-4-azapyrazolo(4',3'-2,3)androstan-17-ol [MeSH Supplementary Concept]
- 2'-(4-fluorophenyl)-4-azapyrazolo(4',3'-2,3)androstan-17-yl acetate [MeSH Supplementary Concept]
- 2,10,11,11a-tetrahydro-11a-methyl-1H-naphth(1,2-g)indol-7-ol [MeSH Supplementary Concept]
- 2,3-bisaza-A-nor-1,5(10)-estradien-17-ol [MeSH Supplementary Concept]
- 2,3-dimethoxy-8-azagona-1,3,5(10),13-tetraene-12,17-dione [MeSH Supplementary Concept]
- 21-diazo-4-methyl-4-azapregnane-3,20-dione [MeSH Supplementary Concept]
- 25-azacoprostane [MeSH Supplementary Concept]
- 3 beta-hydroxy-13 alpha-amino-13,17-seco-5 alpha-androstan-17-oic-13,17-lactam [MeSH Supplementary Concept]
- 3-(((4-(bis(2-chloroethyl)amino)phenyl)acetyl)oxy)-17a-aza-D-homoandrost-5-en-17-one [MeSH Supplementary Concept]
- 3-(indonlylbutanamido)-17a-azahomo-4-androsten-17-one [MeSH Supplementary Concept]
- 3-fluoro-N-(3H-imidazo(4,5-b)pyridin-2-ylmethyl)-1,4a,6a-trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno(5,4-f)quinoline-7-carboxamide [MeSH Supplementary Concept]
- 3-hydroxy-13,17-seco-5-androsten-17-oic-13,17-lactam (4-(bis(2-chloroethyl)amino)phenyl)butyrate [MeSH Supplementary Concept]
- 3-hydroxy-13,17-secoandrostan-17-oic-13,17-lactam (4-(bis(2-chloroethyl)amino)phenyl)butyrate [MeSH Supplementary Concept]
- 3-hydroxy-13-amino-13,17-seco-5alpha-androstan-17-oic-13,17-lactam 2-N,N-bis(2-chloroethyl)aminobenzoate [MeSH Supplementary Concept]
- 3-hydroxy-13-amino-13,17-secoandrostan-17-oic-13,17-lactam p-bis(2-chloroethyl)amino phenyl acetate [MeSH Supplementary Concept]
- 3-hydroxy-17-aza-D-homo-5-androsten-17-one [MeSH Supplementary Concept]
- 3-hydroxy-17-aza-D-homoandrostan-4-N,N-bis(2-chloroethyl)aminophenylacetate [MeSH Supplementary Concept]
- 3-hydroxy-17a-azahomoandrostan-7-one-4-N,N-bis(2-chloroethyl)aminophenyl acetate [MeSH Supplementary Concept]
- 3-hydroxy-3-aza-A-homoandrosten-4-one-4-bis(2-chloroethyl)aminophenoxyacetate [MeSH Supplementary Concept]
- 3-hydroxy-N-methyl-17-aza-D-homoandrostan-17-one-4-N,N-bis(2-chloroethyl)aminophenylacetate [MeSH Supplementary Concept]
- 3-methoxy-17-aza-homoandrost-5-ene-17-one [MeSH Supplementary Concept]
- 4,6-diaza-A,B-dihomo-24-ethylcholest-3,7-dione [MeSH Supplementary Concept]
- 4,6-diaza-A,B-dihomocholest-3,7-dione [MeSH Supplementary Concept]
- 4,7beta-dimethyl-4-azacholestan-3-one [MeSH Supplementary Concept]
- 4-aza-4-methylpregnane-3,20-dione [MeSH Supplementary Concept]
- 4-methyl-4-aza-3-oxopregnane-20-carboxylate [MeSH Supplementary Concept]
- 4-methyl-4-azacholestane [MeSH Supplementary Concept]
- 6,7-diazacholest-8(14)-en-3-ol [MeSH Supplementary Concept]
- 6-aza-B-homocholest-7-en-3-ol [MeSH Supplementary Concept]
- 7a,17a-diaza-7,17-dioxo-B,D-dihomo-5-androsten-3-yl 4-N,N-bis(2-chloroethyl)aminophenylacetate [MeSH Supplementary Concept]
- 8,13-diaza-2,3-dimethoxygona-1,3,5(10),9(11)-tetraen-12-one [MeSH Supplementary Concept]
- ANQ 9040 [MeSH Supplementary Concept]
- D-11-aza-19-nortestosterone [MeSH Supplementary Concept]
- FCE 27837 [MeSH Supplementary Concept]
- FCE 28175 [MeSH Supplementary Concept]
- HS 342 [MeSH Supplementary Concept]
- L 636028 [MeSH Supplementary Concept]
- L 751788 [MeSH Supplementary Concept]
- N,N-diethyl-4-methoxy-3-oxo-4-aza-5-androstene-17-carboxamide [MeSH Supplementary Concept]
- N-(1-(4-methoxyphenyl)-1-methylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide [MeSH Supplementary Concept]
- N-4(benzylbenzoyl)-3-oxo-4-aza-4-methyl-5-androstane-17-carboxamide [MeSH Supplementary Concept]
- N-chloro-3-methoxy-16-aza-1,3,5(10)-estratrien-17-one [MeSH Supplementary Concept]
- N-chloro-3-methoxy-17-aza-homo-1,3,5(10)-estratrien-17-one [MeSH Supplementary Concept]
- N-chloro-3-methoxy-17-azahomo-1,3,5(10)-estratrien-16-one [MeSH Supplementary Concept]
- N-cyano-2-aza-A-norandrostan-17-ol acetate [MeSH Supplementary Concept]
- N-ethyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide [MeSH Supplementary Concept]
- NSC 290205 [MeSH Supplementary Concept]
- NSC 620480 [MeSH Supplementary Concept]
- RU 5135 [MeSH Supplementary Concept]
- STX 213 [MeSH Supplementary Concept]
- UCA 1064-B [MeSH Supplementary Concept]
- cycloneosamandaridine [MeSH Supplementary Concept]
- methoxyimine [MeSH Supplementary Concept]
- samandarone [MeSH Supplementary Concept]
- samanine [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Azasteroid (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients